Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Combinatorial effects of doxorubicin and retargeted tissue factor by intratumoral entrapment of doxorubicin and proapoptotic increase of tumor vascular infarction.
Oncotarget. 2016 Dec 13;7(50):82458-82472. doi: 10.18632/oncotarget.12559.
Oncotarget. 2016.
PMID: 27738341
Free PMC article.
Tumor Growth Inhibition via Occlusion of Tumor Vasculature Induced by N-Terminally PEGylated Retargeted Tissue Factor tTF-NGR.
Brand C, Fröhlich M, Ring J, Schliemann C, Kessler T, Mantke V, König S, Lücke M, Mesters RM, Berdel WE, Schwöppe C.
Brand C, et al. Among authors: mantke v.
Mol Pharm. 2015 Oct 5;12(10):3749-58. doi: 10.1021/acs.molpharmaceut.5b00508. Epub 2015 Aug 31.
Mol Pharm. 2015.
PMID: 26310827
Item in Clipboard
NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor.
Brand C, Schliemann C, Ring J, Kessler T, Bäumer S, Angenendt L, Mantke V, Ross R, Hintelmann H, Spieker T, Wardelmann E, Mesters RM, Berdel WE, Schwöppe C.
Brand C, et al. Among authors: mantke v.
Oncotarget. 2016 Feb 9;7(6):6774-89. doi: 10.18632/oncotarget.6725.
Oncotarget. 2016.
PMID: 26735180
Free PMC article.
Item in Clipboard
Cite
Cite